Pancreatic Cancer Surveillance in High-Risk: No Better Outcomes
NEW YORK (Reuters Health) – Surveillance of people at high hereditary risk for pancreatic duct...
Genomic test helps estimate risk of prostate cancer metastasis, death
A commercially available genomic test may help onc...